Status:

COMPLETED

Predictive Role of HRV for PONV in Laparoscopic Cholecystectomy

Lead Sponsor:

Konya City Hospital

Conditions:

Postoperative Nausea and Vomiting (PONV)

Heart Rate Variability (HRV)

Eligibility:

FEMALE

18-65 years

Brief Summary

Postoperative nausea and vomiting (PONV) are among the most common complications following general anesthesia (GA), significantly affecting patient comfort and recovery. Although various risk factors ...

Eligibility Criteria

Inclusion

  • Female patients aged 18 to 65 years
  • Scheduled for elective laparoscopic cholecystectomy
  • American Society of Anesthesiologists (ASA) physical status I
  • Body mass index (BMI) \< 35 kg/m²
  • Non-smokers
  • Able and willing to provide written informed consent

Exclusion

  • History of cardiovascular, neurological, or gastrointestinal disease
  • Use of medications affecting HRV (e.g., antihypertensives, diuretics, atropine, antidepressants, antipsychotics, steroids)
  • Presence of systemic diseases that may affect PONV risk
  • Inability to comply with study procedures

Key Trial Info

Start Date :

May 2 2025

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 15 2025

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT06948708

Start Date

May 2 2025

End Date

September 15 2025

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Konya City Hospital

Konya, Turkey (Türkiye), 42090

Predictive Role of HRV for PONV in Laparoscopic Cholecystectomy | DecenTrialz